Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Cash-Producing Stocks That Concern Us

By: StockStory

December 01, 2025 at 06:01 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ASYS Cover Image

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. Keeping that in mind, here are three cash-producing companies to steer clear of and a few better alternatives.

Amtech (ASYS)

Trailing 12-Month Free Cash Flow Margin: 7.4%

Focusing on the silicon carbide and power semiconductor sectors, Amtech Systems (NASDAQ: ASYS) produces the machinery and related chemicals needed for manufacturing semiconductors.

Why Is ASYS Risky?

Products and services are facing significant end-market challenges during this cycle as sales have declined by 15.8% annually over the last two years
Persistent operating margin losses suggest the business manages its expenses poorly
Revenue growth over the past five years was nullified by the company’s new share issuances as its earnings per share fell by 17.8% annually

Amtech’s stock price of $7.85 implies a valuation ratio of 60.4x forward P/E. If you’re considering ASYS for your portfolio, see our FREE research report to learn more.

Herc (HRI)

Trailing 12-Month Free Cash Flow Margin: 5.6%

Formerly a subsidiary of Hertz Corporation and with a logo that still bears some similarities to its former parent, Herc Holdings (NYSE: HRI) provides equipment rental and related services to a wide range of industries.

Why Does HRI Worry Us?

Earnings per share fell by 15.2% annually over the last two years while its revenue grew, showing its incremental sales were much less profitable
Free cash flow margin shrank by 9.4 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
High net-debt-to-EBITDA ratio of 6× increases the risk of forced asset sales or dilutive financing if operational performance weakens

At $134.27 per share, Herc trades at 17.7x forward P/E. Check out our free in-depth research report to learn more about why HRI doesn’t pass our bar.

ICU Medical (ICUI)

Trailing 12-Month Free Cash Flow Margin: 3.1%

Founded in 1984 and named for its initial focus on intensive care units, ICU Medical (NASDAQ: ICUI) develops and manufactures medical products for infusion therapy, vascular access, and vital care applications used in hospitals and other healthcare settings.

Why Should You Dump ICUI?

Sales trends were unexciting over the last two years as its 1.5% annual growth was below the typical healthcare company
Projected sales decline of 8.5% for the next 12 months points to a tough demand environment ahead
Free cash flow margin dropped by 11.3 percentage points over the last five years, implying the company became more capital intensive as competition picked up

ICU Medical is trading at $148.52 per share, or 20x forward P/E. To fully understand why you should be careful with ICUI, check out our full research report (it’s free for active Edge members).

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	253.79	+3.77 (1.51%)
AAPL	311.23	+0.97 (0.31%)
AMD	523.20	-19.32 (-3.56%)
BAC	54.17	+1.77 (3.38%)
GOOG	369.27	+13.59 (3.82%)
META	627.57	+4.59 (0.74%)
MSFT	428.05	+0.71 (0.17%)
NVDA	218.66	+3.91 (1.82%)
ORCL	236.34	+6.01 (2.61%)
TSLA	418.45	-5.25 (-1.24%)